U.S. Pharma Stock News

NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Is It Too Late To Consider Marvell Technology (MRVL) After Its 165% One-Year Rally?

If you are wondering whether Marvell Technology at US$170.84 is priced for perfection or still offers value, the next sections will help you frame that question clearly. The stock has delivered returns of 4.4% over the past week, 33.0% over the last month, 91.1% year to date and 165.6% over the last year, with 3-year and 5-year returns of 310.2% and 306.9% respectively. Recent coverage has focused on Marvell's positioning within the semiconductor sector and how investors are reacting to its...
NasdaqGM:AGNT
NasdaqGM:AGNTReal Estate

AGNT Rebrands eXp With NextHome Acquisition And Multi Model Upside

eXp World Holdings, now trading under the ticker NasdaqGM:AGNT, has acquired franchise based brokerage NextHome. The company is shifting to a multi model real estate platform that offers both cloud brokerage and franchise options for agents and brokers. The new structure brings multiple brands under one global umbrella, with the AGNT ticker reflecting the broader platform focus. For real estate investors, NasdaqGM:AGNT now represents more than a pure cloud brokerage business. The...
NYSE:PHIN
NYSE:PHINAuto Components

PHINIA (PHIN) Is Up 8.1% After Debuting Hydrogen Van And Boosting Capital Returns - Has The Bull Case Changed?

In early May 2026, PHINIA Inc. showcased its first homologated hydrogen internal combustion engine light commercial vehicle at ACT Expo in Las Vegas, highlighting lower-carbon technology developed with Aramco that meets Euro 7 standards and targets very large reductions in tailpipe CO2 emissions versus diesel. The company coupled this technology milestone with a solid first-quarter earnings report, higher year-on-year sales and net income, continued 2026 guidance, and completion of a...
NasdaqGS:HEPS
NasdaqGS:HEPSMultiline Retail

A Look At Hepsiburada (HEPS) Valuation After Growth-Focused Earnings And Wider Net Loss

D-Market Elektronik Hizmetler ve Ticaret (HEPS) is back on investors’ radar after reporting first quarter 2026 results, with higher sales and gross merchandise value alongside a wider net loss driven by growth investments. See our latest analysis for D-Market Elektronik Hizmetler ve Ticaret. The earnings release appears to have cooled very short term sentiment, with the share price down 2.48% over the last day and 1.43% over the week. However, a 7.42% year to date share price return contrasts...
NYSE:D
NYSE:DIntegrated Utilities

How Investors Are Reacting To Dominion Energy (D) Earnings Beat, Dividend Payout And New Debt Program

Dominion Energy’s recent quarterly update showed first-quarter 2026 sales rising to US$5,019 million while net income eased to US$621 million, alongside a confirmed quarterly dividend of US$0.6675 per share and a new US$3.00 billion shelf registration for floating rate demand notes with a dividend reinvestment plan. The company’s stronger-than-expected profit and revenue, reaffirmed earnings outlook, and rejection of shareholder proposals on governance and ESG-linked pay together highlight...
NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

Pennant Group (PNTG) Is Up 9.7% After Q1 2026 Beat And Senior Living Expansion - Has The Bull Case Changed?

The Pennant Group, Inc. has already reported first-quarter 2026 results, with sales rising to US$285.36 million and net income to US$8.52 million, while also assuming operations of three senior living communities across Arizona and Wisconsin totaling 194 units. Together, the stronger earnings and continued expansion of Pennant’s senior living footprint highlight how the company is actively scaling its post-acute care and housing platform. Next, we’ll examine how Pennant’s stronger Q1...
NYSE:LXU
NYSE:LXUChemicals

What LSB Industries (LXU)'s Profit Rebound and Expansion Plans Mean For Shareholders

In late April 2026, LSB Industries, Inc. reported first-quarter sales of US$169.49 million and net income of US$19.69 million, reversing a loss a year earlier. Alongside this earnings improvement, management highlighted active review of debottlenecking projects and potential acquisitions or partnerships to expand fertilizer and industrial production capacity and gain scale. With earnings swinging to profit and management evaluating capacity-expanding investments, we’ll now examine how this...
NYSE:NGVT
NYSE:NGVTChemicals

Should Ingevity’s Divestiture-Driven Earnings and ESOP Shelf Filing Prompt Strategic Reassessment From NGVT Investors?

Ingevity Corporation recently reported past first-quarter 2026 results showing sales of US$258 million, net income of US$59.8 million, and earnings lifted by gains from divesting its Industrial Specialties and Road Markings product lines. The company also filed a US$45.16 million shelf registration for 580,000 common shares tied to its ESOP, highlighting ongoing capital management alongside a pivot toward higher-margin core businesses. Against this backdrop, we will now examine how the...
NYSE:PFE
NYSE:PFEPharmaceuticals

If AI Reshapes Healthcare, These Three Stocks Could Lead

AI in healthcare sits at the crossroads of powerful themes investors are already watching, from inflation and tighter financing conditions to pressure on productivity and public budgets. As energy costs and rates keep policy makers on alert, hospitals, insurers and drug developers are under pressure to do more with less, while patients still want faster, more accurate care. The Transformative AI Healthcare Stocks screener filters for companies using AI to tackle diagnostics, treatment and...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

How Investors May Respond To Atlanta Braves Holdings (BATR.K) Strong Q1 Revenue Amid Continuing Losses

Atlanta Braves Holdings, Inc. has reported past first-quarter 2026 results showing revenue of US$72.01 million versus US$47.21 million a year earlier, with a net loss of US$40.48 million and basic and diluted loss per share of US$0.63. The combination of higher revenue and a slightly narrower loss highlights how the Braves’ media and stadium-driven business model can add scale even while the team remains loss-making. We’ll now examine how this stronger year-over-year revenue performance...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Three High ROE Stocks With Quietly Powerful Balance Sheets

Markets are wrestling with higher inflation, rising bond yields and volatile energy prices, so quality balance sheets matter more than ever. When borrowing costs and policy expectations shift frequently, companies with strong return on equity, resilient past performance and solid finances can give you cleaner exposure to long term growth stories, without relying on heavy leverage or speculative turnarounds. This article focuses on a curated screener that looks exactly for that mix of quality...
NYSEAM:IE
NYSEAM:IEMetals and Mining

Why Ivanhoe Electric (IE) Is Up 12.2% After Alacrán Sale Boosts Profit And Funds Exploration

Ivanhoe Electric’s first-quarter 2026 results showed sales of US$858,000 and net income of US$41.74 million, a sharp turnaround from a net loss a year earlier, largely reflecting a very large gain from subsidiary Cordoba’s sale of the Alacrán copper-gold project. Alongside this profit swing, Ivanhoe Electric increased exploration spending at assets such as the Santa Cruz Copper Project and entered new copper-focused collaborations, including a partnership with SQM Chile, reshaping how...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

The Bull Case For Celldex Therapeutics (CLDX) Could Change Following Q1 Loss And Barzolvolimab Milestones

Celldex Therapeutics recently reported first-quarter 2026 results, with revenue falling to US$15,000 from US$695,000 a year earlier and net loss widening to US$78.69 million, while accelerating investment in late-stage development of its lead antibody barzolvolimab. At the same time, Celldex completed Phase 3 enrollment for barzolvolimab in chronic spontaneous urticaria six months ahead of plan and raised about US$345 million in a follow-on offering, extending its funding runway for ongoing...
NasdaqGM:NBN
NasdaqGM:NBNBanks

A Look At Northeast Bank (NBN) Valuation After Strong Year Over Year Earnings Growth

Key earnings details from Northeast Bank’s latest report Northeast Bank (NBN) posted third quarter results that highlighted year over year changes in profitability, including net interest income of US$63.07 million and net income of US$29.85 million for the period ended March 31, 2026. For the first nine months of the fiscal year, the bank reported net interest income of US$160.07 million and net income of US$73.14 million, giving investors fresh data to assess recent performance and earnings...
NYSE:PCOR
NYSE:PCORSoftware

A Look At Procore Technologies (PCOR) Valuation After Strong Q1 2026 Results And Raised Guidance

Procore Technologies (PCOR) is back in focus after its first quarter 2026 update, which combined higher revenue, a narrower net loss, raised full year guidance, fresh AI moves, and active share repurchases. See our latest analysis for Procore Technologies. Despite the stronger first quarter story and raised 2026 guidance, Procore Technologies' share price return is down 23.9% year to date and total shareholder return is down 26.2% over the past year. The 1 month share price return of 12.9%...
NYSE:AGBK
NYSE:AGBKBanks

Is AGI (AGBK) Offering A Rare Opportunity After A 34.8% Year To Date Slide?

Wondering whether AGI at around US$7.01 is a bargain or a value trap? This article walks through the key valuation clues that can help you frame that question. Over the last week the stock gained 2.9%, while over the past month it fell 1.3% and year to date it is down 34.8%. This naturally raises questions about how the market is currently pricing its prospects and risks. Recent coverage has focused on AGI's position in the US banking sector and how its share price has reacted to shifts in...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

RadNet (RDNT) Q1 Loss Widens Again And Tests Bullish AI Margin Narrative

RadNet Q1 2026 earnings: revenue expands while margins stay under pressure RadNet (RDNT) opened 2026 with Q1 revenue of US$575.6 million and a basic EPS loss of US$0.43, as the stock trades around US$58.19. The company has seen revenue move from US$471.4 million in Q1 2025 to US$575.6 million in Q1 2026, while quarterly EPS has shifted from a loss of US$0.51 to a loss of US$0.43 over the same period. This sets up a results season where investors are watching how quickly revenue scale can...